Ibex Wealth Advisors Horizon Therapeutics Public LTD CO Transaction History

Ibex Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $2.89 Million - $3.67 Million	-33,436 Closed	0 $0
Q4 2021 Feb 22, 2022	BUY	$98.56 - $119.91 $66,232 - $80,579	672 Added 2.05%	33,436 $3.6 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $78,674 - $94,476	856 Added 2.68%	32,764 $3.59 Million
Q2 2021 Aug 20, 2021	SELL	$86.24 - $95.92 $105,730 - $117,597	-1,226 Reduced 3.7%	31,908 $2.99 Million
Q1 2021 May 05, 2021	BUY	$71.83 - $95.48 $400,595 - $532,491	5,577 Added 20.24%	33,134 $3.05 Million
Q4 2020 Jan 22, 2021	BUY	$67.0 - $84.39 $316,173 - $398,236	4,719 Added 20.66%	27,557 $2.02 Million
Q3 2020 Oct 23, 2020	BUY	$55.23 - $79.93 $1.26 Million - $1.83 Million	22,838 New	22,838 $1.77 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Ibex Wealth Advisors with notifications on news.